Tycel Phillips, MD^1*, Catherine Thieblemont, MD, PhD^2,3, Herve Ghesquieres, MD, PhD^4*, Chan Y. Cheah⁵, Michael Roost Clausen, MD, PhD^6*, David Cunningham, MD, FRCP, FMedSci^7*, Young Rok Do, MD, PhD⁸, Tatyana A. Feldman, MD⁹, Robin Gasiorowski, MA, FRACP, FRCPA, MBBS¹⁰, Wojciech Jurczak¹¹, Tae Min Kim, MD, PhD^12*, David John Lewis, MBChB, PhD^13,14*, Marjolein van der Poel, MD, PhD^15,16,17,18, Michelle Limei Poon, MBBS, MRCP^19*, Nurgul Kilavuz, PharmMS^20*, Mariana Cota Stirner, MD, PhD²¹, David Soong, PhD²⁰, Christopher Chiu, PhD²², Menghui Chen, PhD^20*, Mariana Sacchi, MD^20*, Brian Elliot, MD^20*, Martin Hutchings, MD, PhD^23* and Pieternella Lugtenburg, MD, PhD²⁴

¹University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
²APHP, Saint-Louis Hospital, Paris, France
³Université de Paris, Paris, France
⁴Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre-Bénite, France
⁵Sir Charles Gairdner Hospital, Nedlands, Australia
⁶Vejle Hospital, Vejle, Denmark
⁷The Royal Marsden NHS Foundation Trust, London, United Kingdom
⁸Keimyung University Dongsan Medical Center, Daegu, Korea, Republic of (South)
⁹Hackensack Meridian Health Hackensack University Medical Center, Hackensack, NJ
¹⁰Concord Hospital, University of Sydney, Concord, NSW, Australia
¹¹MSC National Research Institute of Oncology, Krakow, Poland
¹²Seoul National University Hospital, Seoul, Korea, Republic of (South)
¹³University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom
¹⁴Derriford Hospital, Plymouth, United Kingdom
¹⁵Maastricht University Medical Center, Maastricht, Netherlands
¹⁶On behalf of the Lunenburg Lymphoma Phase I/II Consortium-HOVON/LLPC, Maastricht, Netherlands
¹⁷GROW School for Oncology and Developmental Biology, Maastricht, Netherlands
¹⁸Department of Hematology, Maastricht University Medical Center, Maastricht, Netherlands
¹⁹National University Hospital, Singapore, Singapore
²⁰Genmab, Princeton, NJ
²¹AbbVie, North Chicago, IL
²²Translational Research and Precision Medicine Operations, Genmab, Princeton, NJ
²³Rigshospitalet - Copenhagen University Hospital, Copenhagen, Denmark
²⁴Department of Hematology, On behalf of the HOVON lymphoma working group, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, Netherlands

Tamer Othman, MD^1*, Christopher Ruel^2*, Paul Frankel, PhD^2*, Alexander A. Merleev, PhD^1*, Guillaume Luxardi, PhD^1*, Emanual Maverakis, MD^1*, Mehrdad Abedi, MD¹, Raghuveer Ranganathan, MD^3*, Jasmine Zain, MD², Elizabeth L. Budde, MD, PhD⁴, Matthew Mei, MD², Aaron S Rosenberg, MD¹, Rasmus T Hoeg, MD^1*, Caitlin Costello, MD⁵, Francine M. Foss, MD⁶, Basem M. William, MRCP, MD⁷, H. Kent Holland, MD⁸, Miguel Villalona-Calero, MD^2*, Elad Sharon, MD, MPH^9* and Joseph M Tuscano, MD¹

¹University of California Davis Comprehensive Cancer Center, Sacramento, CA
²City of Hope, Duarte, CA
³Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA
⁴Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
⁵Moores Cancer Center, University of California San Diego, La Jolla, CA
⁶Hematology, Yale Cancer Center, New Haven, CT
⁷The James Cancer Center, Ohio State University, Columbus, OH
⁸Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA
⁹Division of Cancer Treatment and Diagnosis, National Cancer Institute, Cancer Therapy Evaluation Program, Bethesda, MD

Georgios Pongas, MD¹, Ngoc L Toomey, BS^2*, Isildinha M. Reis, PhD^3*, Krishna V. Komanduri, MD⁴, Jennifer R Chapman-Fredricks, MD^5* and Juan Carlos Ramos, MD⁶

¹Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL
²Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
³Division of Biostatistics, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL
⁴Division of Transplantation and Cellular Therapy, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
⁵University of Miami Miller School of Medicine, Miami, FL
⁶Division of Hematology, University of Miami, Miami, FL

Qingqing Cai, PhD¹, Yi Xia, MD, PhD^2*, Hui Zhou^3*, Wenyu Li⁴, Zhiming Li^2*, Xu Ye, MD, PhD^5*, Yudan Wu, MD^6*, Huo Tan, MD, PhD⁷, Runhui Zheng, MD, PhD^7*, Bingyi Wu, MD, PhD⁸, Hui Yang, MD, PhD^8*, Yuhong Lu, MD, PhD^9*, Yang Liang, MD, PhD¹⁰, Ning Su, MD^11*, Qihua Zou, MM^1* and Panpan Liu, MD, PhD^1*

¹Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
²Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
³Department of Lymphoma and Hematology, Hunan Cancer Hospital, Changsha, China
⁴Department of Lymphoma, Guangdong Academy of Medical Science, Guangdong Provincial People's Hospital, Guangdong, China
⁵Department of Hematology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
⁶Department of Hematology, The Second Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China
⁷Department of Hematology, The First Affiliation Hospital of Guangzhou Medical University, Guangzhou, China
⁸Department of Hematology, Shunde Hospital of Southern Medical University, Foshan, China
⁹International Cancer Medical Center, Jinshazhou Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China
¹⁰State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine; Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
¹¹Department of Oncology, Guangzhou Chest Hospital, Guangzhou, China

Xi Chen^*, Tao Lei, MD^*, Haifeng Yu, MD^*, Cong Li, MD, Shuiyun Han^*, Shuailing Peng^* and Haiyan Yang, PhD

Department of Lymphatic Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences（Zhejiang Cancer Hospital），Institute of Basic Medicine and Cancer（IBMC），Chinese Academy of Sciences, Hangzhou, China

Mazyar Shadman, MD¹, Anthony R. Mato, MD, MSCE², Connie Lee Batlevi, MD, PhD³, Ian W. Flinn, MD PhD⁴, Martin Gutierrez, MD^5*, Marc Uemura^6*, Don A. Stevens, MD⁷, Daniel Morillo, MD^8*, John C. Byrd, MD⁹, Melanie M. Frigault, PhD¹⁰, George Clemens, PhD^10*, Xin Huang^10*, Raquel Izumi, PhD¹⁰, Harvey Wong^10*, Renee Breed^10*, Hermes Garban^10*, Amy J. Johnson, PhD¹⁰, Beatrix Stelte-Ludwig, PhD^11*, Arushi Mithal^10*, Joseph Birkett, PhD^10*, Ahmed Hamdy, MD¹⁰ and Kerry A. Rogers, MD¹²

¹University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA
²CLL Program, Leukemia Service, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
³Memorial Sloan Kettering Cancer Center, New York, NY
⁴Sarah Cannon Research Institute, Nashville, TN
⁵Hackensack University Medical Center, Hackensack, NJ
⁶Willamette Valley Cancer Institute, Eugene, OR
⁷Norton Cancer Institute, Norton Health Care, Louisville, KY
⁸START Madrid-FJD, Hospital Fundación Jiménez Díaz, LAS ROZAS, Spain
⁹University of Cincinnati College of Medicine, Cincinnati, OH
¹⁰Vincerx Pharma Inc, Palo Alto, CA
¹¹Vincerx Pharma GmbH, Monheim, Germany
¹²The Ohio State University Comprehensive Cancer Center, Columbus, OH

Susan M. O'Brien¹, Loretta J. Nastoupil, MD², James Essell, MD³, Ly Dsouza, PA-C^4*, Doug Hart^3*, Emiri Matsuda^1*, Tarah Satterfield^5*, Tonia Nesheiwat^6*, Ashley Hammad^6*, Franco Davi^6*, Shally Chung^6*, S. Asim Shamsi^6*, Mara Bryan^6*, Justin Skoble^6*, Elizabeth Garner^6*, Steven Kanner, PhD⁶, Syed Rizvi, MD⁶ and Houston Holmes, MD^5*

¹Chao Family Comprehensive Cancer Center, University of California-Irvine, Irvine, CA
²Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
³Oncology Hematology Care, Cincinnati, OH
⁴Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Texas Oncology/Baylor-Sammons Cancer Center, Dallas, TX
⁶Caribou Biosciences, Berkeley, CA

Lijuan Deng, MD^1*, Tianheng He^2*, Di Mei^2*, Yongjing Tang^1*, Changyu Lu^3*, Xian Zhang⁴, Meixiang Zhang, MD^5*, Feng Chen^6*, Xiaopei Wang^1*, Jun Zhu, PhD¹ and Yuqin Song, MD⁷

¹Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China
²Department of Lymphoma, Peking University International Hospital, Beijing, China
³Department of neurosurgery, Peking University International Hospital, Beijing, China
⁴Hebei Yanda Lu Daopei Hospital, Langfang, China
⁵Department of Hematogogy, Peking University International Hospital, Beijing, China
⁶Department of Neuro-Oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
⁷Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, BEIJING, China

Martin Hutchings, MD, PhD^1*, Carmelo Carlo-Stella, MD, PhD², Giuseppe Gritti^3*, Francesc Bosch, MD, PhD^4,5, Franck Morschhauser, MD, PhD^6*, William Townsend^7*, Fritz Offner, MD, PhD⁸, Harriet S Walter^9*, Herve Ghesquieres, MD, PhD^10*, Roch Houot, MD, PhD^11*, Guillaume Cartron, MD, PhD^12*, Natalie Dimier, PhD^13*, Stephen Fowler^14*, Emma Harrop^15*, Sylvia Herter, PhD^16*, Abiraj Keelara, PhD^17*, Koorosh Korfi, PhD^14*, Jeff Luong^18*, Claudia Mueller^19*, Robert Nutbrown^20*, Giuseppe Palldino^21*, Matt Whayman^13*, Isabel Prieto^22*, Sarah Louise Mycroft^13*, Daria Rukina^23*, Katharina E Lechner^24* and Michael Dickinson, MD²⁵

¹Department of Haematology and Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark
²Department of Oncology and Hematology, Humanitas University and IRCCS Humanitas Research Hospital, Milan, Italy
³Ematologia, AASST PAPA GIOVANNI XXIII, Bergamo, Italy
⁴Hospital Universitari Vall d’Hebron, Barcelona, Spain
⁵Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), University Autonoma of Barcelona (UAB), Barcelona, Spain
⁶Hematology Department, Lille University Hospital, Lille, France
⁷National Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Foundation Trust and UCLH, London, United Kingdom
⁸Universitair Ziekenhuis Gent, Ghent, Belgium
⁹The HOPE Clinical Trials Unit, Leicester, United Kingdom
¹⁰Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Lyon, France
¹¹Department of Hematology, Rennes University Hospital, Rennes, France
¹²Department of Hematology, CHU Montpellier, Montpellier, France
¹³Roche Innovation Center Welwyn, Roche Ltd, Welwyn, United Kingdom
¹⁴Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland
¹⁵Roche Innovation Center Welwyn, Roche Pharma Research and Early Development, Welwyn, United Kingdom
¹⁶Roche Innovation Center Zurich, Schlieren, Switzerland
¹⁷Roche Innovation Center Basel,, Roche Pharma Research and Early Development, Basel, Switzerland
¹⁸Hoffmann-La Roche Limited, Mississauga, Canada
¹⁹Roche Innovation Center Munich, Roche Pharma Research and Early Development, Penzberg, Germany
²⁰Roche Innovation Center Welwyn, Roche Pharama Research and Early Development, Welwyn, United Kingdom
²¹A4P Consulting Ltd., Sandwich, United Kingdom
²²Roche Innovation Center Welwyn, Roche Ltd., Welwyn, United Kingdom
²³Roche Innovation Center Basel, Roche, Pharma Research Early Development, Basel, Switzerland
²⁴Roche Innovation Center Munich, Roche Pharma Research and Early Development, Munich, Germany
²⁵Peter MacCallum Cancer Centre, Melbourne, Australia

Laurie H. Sehn, MD, MPH¹, Mark Hertzberg, MBBS^2*, Stephen Opat, FRACP, FRCPA, MBBS^3*, Alex F. Herrera, MD⁴, Sarit Assouline⁵, Christopher R. Flowers, MD⁶, Tae Min Kim, MD, PhD^7*, Andrew K. McMillan, MD⁸, Muhit Özcan, MD^9*, Violaine Safar, MD^10*, Gilles Salles, MD, PhD¹⁰, Jamie Hirata, PharmD¹¹, Annie Yang^11*, Lisa Musick, PharmD^11* and Matthew J. Matasar, MD, MS¹⁰

¹BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, Canada
²Prince of Wales Hospital and University of NSW, Sydney, Australia
³Clinical Haematology, Monash Health and Monash University, Clayton, Australia
⁴City of Hope Medical Centre, Duarte, CA
⁵Jewish General Hospital, Montreal, Canada
⁶Winship Cancer Institute of Emory University, Atlanta, GA
⁷Seoul National University Hospital, Seoul, Korea, Republic of (South)
⁸Centre for Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
⁹Ankara University, Ankara, Turkey
¹⁰Memorial Sloan Kettering Cancer Center, New York, NY
¹¹Genentech, Inc., South San Francisco, CA

Anna Dodero, MD^1*, Stefania Bramanti, MD^2*, Martina Pennisi^1*, Silva Ljevar^3*, Annalisa Chiappella, MD⁴, Massimo Magagnoli, MD^2*, Anna Guidetti, MD^1,5, Francesco Corrado^2*, Paulina Nierychlewska, MD^6*, Alice Di Rocco, MD^7*, Antonello Domenico Cabras, MD^8*, Daoud Rahal^9*, Chiara De Philippis, MD^2*, Armando Santoro, MD^2,10*, Carmelo Carlo-Stella, MD, PhD^11,12 and Paolo Corradini, MD^1,13

¹Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
²Hematology, IRCCS Humanitas Research Hospital, Rozzano-Milano, Italy
³Unit of Clinical Epidemiology and Trial Organization; Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milano, Italy
⁴Division of Hematology & Stem Cell Transplant, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Milano, Italy
⁵Università di Milano, Milano, Italy
⁶Hematology, Istituto Tumori Giovanni Paolo II, Bari, Italy
⁷Unit of Hematology, Azienda Ospedaliero-Universitaria Policlinico Umberto I, Roma, Italy
⁸Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
⁹Pathology, IRCCS Humanitas Research Hospital, Rozzano - Milan, Italy
¹⁰Department of Biomedical Sciences, Humanitas University, Milan, Italy
¹¹Humanitas University and IRCCS Humanitas Research Hospital, Milan, Milano, Italy
¹²Department of Biomedical Sciences, Humanitas University, Milano, Italy
¹³Universita' di Milano, Milano, Italy

Krish Patel, MD¹, Peter A. Riedell, MD², Hervé Tilly, MD, PhD³, Sairah Ahmed, MD⁴, Jean-Marie Michot, MD^5*, Herve Ghesquieres, MD, PhD^6*, Jean Marc Schiano de Collela, MD^7*, Asher Chanan-Khan, MD⁸, Kamal Bouabdallah, MD^9*, Benoit Tessoulin, MD^10*, Sunil Iyengar^11*, Meixiao Long, MD¹², Raphael Clynes, MD, PhD^13*, Jitendra Kanodia, PhD^13*, Lei Bao^14*, Ying Ding^15*, Jianhua Jin, MS^13*, William B Ainsworth, PhD¹⁶, Raman Garcha, MD^16*, Steve Kye, MD, MPH¹³ and Tycel J. Phillips, MD¹⁷

¹Swedish Cancer Institute, Center for Blood Disorders and Cellular Therapy, Seattle, WA
²Department of Medicine, Washington University School of Medicine, Chicago, IL
³Centre Henri Becquerel, Rouen, France
⁴Department of Lymphoma/Myeloma and Stem Cell Transplantation, The University of Texas M D Anderson Cancer Center, Houston, TX
⁵Gustave Roussy Cancer Campus, Villejuif, France
⁶Department of Hematology, Lyon Sud University Hospital/Hospices Civils de Lyon, Pierre Benite, France
⁷Institut Paoli Calmettes, Department of Hematology, Marseille, France
⁸Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL
⁹Hematology Clinic, University Hospital of Bordeaux, Pessac, France
¹⁰Hematology Department, Nantes University Hospital, Nantes, France
¹¹Royal Marsden Hospital, London, United Kingdom
¹²Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
¹³Xencor, Inc., Monrovia, CA
¹⁴Xencor, San Diego, CA
¹⁵Xencor Inc., San Diego, CA
¹⁶Xencor, Inc., San Diego, CA
¹⁷University of Michigan Medical School, Ann Arbor, MI

Junyuan Qi, MD, PhD^1*, Keshu Zhou^2*, Wenbin Qian, MD, PhD³, Aimin Zang, MD^4*, Tapan M. Kadia, MD⁵, Andrew H. Lipsky, MD⁶, Yanli Yang, MD^7*, Yu Wang, MD, PhD^8*, Haige Shen, PhD^8*, Bo Zheng, PhD^8*, Chanli Zheng, MD^8*, Dragan Cicic, MD⁹ and Jianxiang Wang, MD¹

¹Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
²Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
³The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
⁴Affiliated hospital of Hebei University, Baoding, China
⁵Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY
⁷The First Affiliated Hospital of Bengbu Medical Collegue, Bengbu, China
⁸GenFleet Therapeutics, Shanghai, China
⁹Sellas Life Sciences Group, New York, NY

Jason Westin, MD¹, Alejandro Martín García-Sancho, MD, PhD^2*, Marc Hoffmann, MD³, Theodoros P. Vassilakopoulos, MD^4*, Su-Peng Yeh, MD^5*, Argyrios Gkasiamis, MD⁶, Poliana Patah^7*, Arpankumar Patel^7*, Ju Li, PhD^7* and Grzegorz S. Nowakowski, MD⁸

¹MD Anderson Cancer Center, Houston, TX
²Hospital Universitario de Salamanca, IBSAL, Salamanca, Spain
³The University of Kansas Cancer Center, Kansas City, KS
⁴Department of Hematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece
⁵China Medical University Hospital, Taichung, Taiwan
⁶Bristol Myers Squibb, Boudry, Switzerland
⁷Bristol Myers Squibb, Princeton, NJ
⁸Mayo Clinic, Rochester, MN

Andrew J Davies, BSc, BM, FRCP, PhD^1,2*, Josh Caddy, BSc^3*, Katy McLaughlin, BSc^3*, Christopher Wignall, MSc^3*, Robert Waugh, MSc^3*, Graham P. Collins, MBBS, MA, MRCP, FRCPath, DPhil⁴, Louise Stanton, MSc^3*, Geoff N Saunders, MSc^3*, Thomas Cummin, FRCPath, PhD^5*, Anna Schuh, MD, PhD, FRCP, FRCPath⁶, Kirit M. Ardeshna⁷, Andrew K. McMillan, MD⁸, John Radford, MD, FRCPath, FMedSci^9*, David John Lewis, MBChB, PhD^10*, Adam R Coleman, PhD^1*, Gareth Griffiths, PhD^3*, Cathy Burton, MBBChir, MA, MD, FRCPath^11*, Sharon Barrans, PhD^11* and Peter Johnson, MD, FRCP^1,12

¹Cancer Research UK Experimental Cancer Medicines Centre UK, Southampton, United Kingdom
²Southampton Cancer Research UK Centre, Southampton, United Kingdom
³Cancer Research UK Southampton Clinical Trials Unit, University of Southampton, Southampton, United Kingdom
⁴Oxford Cancer and Haematology Centre, Churchill Hospital, Oxford, United Kingdom
⁵Portsmouth Hospitals University NHS Trust, Portsmouth, United Kingdom
⁶Oxford Molecular Diagnostic Centre, University of Oxford, Oxford, United Kingdom
⁷Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
⁸Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
⁹NIHR Clinical Research Facility, University of Manchester and the Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom
¹⁰Department of Haematology, Derriford Hospital, Plymouth, United Kingdom
¹¹Haematological Malignancy Diagnostic Service, Leeds Cancer Centre, Leeds, United Kingdom
¹²School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom

Hui Shi, MD^* and Kai Hu, M.D., Ph.D.^*

Department of Adult Lymphoma, Beijing GoBroad Boren Hospital, Beijing, China

Yuankai Shi^1*, Yan Qin^1*, Aimin Zang, MD^2*, Yufu Li, MD^3*, Yanli Yang, MD^4*, Hui Liu, MD^5*, Sujun Gao, MD^6*, Xinghe Wang, MD^7*, Weijing Zhang, MD^7*, Zhengming Jin, MD^8*, Hui Zhou^9*, Wang Hua-Qing, MD & PhD^10* and Min Wei^11*

¹Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China
²Department of Oncology, The Affiliate Hospital of Hebei Medical University, Baoding, China
³Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
⁴The First Affiliated Hospital of Bengbu Medical Collegue, Bengbu, China
⁵Department of Hematology, Beijing Hospital, Beijing, China
⁶Department of Hematology, The First Hospital of Jilin University, Changchun, China
⁷Beijing Shijitan Hospital Affiliated to Capital Medical University, Beijing, China
⁸The First Affiliated Hospital of Soochow University, Suzhou, China
⁹Department of Lymphoma & Hematology, Hunan Cancer Hospital/The Affiliated Tumor Hospital of Xiangya Medical School, Central South University, Changsha, China
¹⁰Department of Oncology, Tianjin People's Hospital, Tianjin, China
¹¹Medical department, Beijing Mabworks Biotech Co. Ltd., Beijing, China

Wei Xu¹, Jin-Hua Liang, MD, PhD^2*, Li Wang^1*, Xiao-Dong Wang, MD, PhD^3*, Guohui Cui, MD, PhD^4*, Jianfeng Zhou, MD^5*, Jingyan Xu, MD⁶, Luqun Wang^7*, Rong Liang, MD, PhD^8*, Bi-yun Chen, MD, PhD^9*, Jian Cheng, PhD^10* and Jian-Yong Li, MD, PhD¹¹

¹Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, China, Nanjing, China, Nanjing, China
²Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China, Nanjing, China
³Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospita, School of Medicine of University of Electronic Science and Technology of China, Chengdu 610000, China, Chengdu, China
⁴Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
⁵Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
⁶Department of Hematology, Nanjing Drum Tower Hospital, Nanjing, China
⁷Department of Hematology, Qilu Hospital of Shandong University, Shandong, Shandong, China
⁸Department of Hematology, Xijing Hospital, The Fourth Military Medical University, Xi'an 710032, China, Xi'an, China
⁹Department of Hematology, Fujian Provincial Hospital, Fujian, China
¹⁰Department of Hematology, Zhongda Hospital, Medical School of Southeast University, Nanjing 210009, China, Nanjing, China
¹¹Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, China, Nanjing, China

Panruo Jiang, MD^1*, Hui Li, MD^1*, Chongyun Xing, MD^1*, Rongqi Li, BPharm^2*, Songfu Jiang, MD^1*, Kang Yu, MD^1* and Haige Ye, MD, PhD^1*

¹Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
²Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China

Saliou Diop Sr., MD, MSc¹, Charline Moulin, MD^2*, Sokhna Aïssatou Touré^1*, Mourtalla Gueye, MD^1*, Sabine Deltour^3*, Yankhoba Diop, MD^4*, Fatou Samba Ndiaye, MD^5*, Mouhamadou Cherif Dial, MD^6*, Hervé Sartelet, MD, PhD^7*, Moussa Seck, MD^8*, Seynabou Fall, MD^8*, Alioune Badara Senghor^1*, Awa Oumar Touré, MD, PhD^8*, Blaise Felix Faye^9*, Elimane Seydi Bousso, MD^9*, Alioune Badara Diallo^1*, Mohamed Keita^9*, Elhadji Daouda Niang^1*, Nata Dieng^1*, Elsa Aboud^7*, Catherine Thieblemont, MD, PhD¹⁰, Vincent Lévy^11*, Marie C Béné, PharmSciD, PhD^12*, Julien Broséus, MD PhD^13*, Martine Raphael, MD, PhD^14* and Pierre Feugier, MD, PhD^15*

¹Service d’Hématologie clinique Université Cheikh Anta Diop, Dakar, Senegal
²Hematology Department, Nancy University Hospital, Vandoeuvre-lès-Nancy, France
³Hématologie Clinique CHRU Nancy, Université de Lorraine, Vandoeuvre-lès-Nancy, France
⁴Service d’anatomo-pathologie Hôpital Principal de Dakar, Dakar, Senegal
⁵Hematology Cheikh Anta Diop University, Dakar, AE, Senegal
⁶Service d’anatomo-pathologie Université Cheikh Anta Diop, Dakar, Senegal
⁷Service d’anatomo-pathologie CHRU Nancy, Université de Lorraine, Vandoeuvre-lès-Nancy, France
⁸Hematology Cheikh Anta Diop University, Dakar, Senegal
⁹Service d’Hématologie clinique Université Cheikh Anta Diop, Dakar, SEN
¹⁰Hemato-oncology Department, Université de Paris Cité/Saint-Louis University Hospital/AP-HP, Paris, France
¹¹Department of Clinical Research, APHP, Hôpital Avicenne, Bobigny, France
¹²Biology Department, Nantes University Hospital, Nantes, France
¹³Haematology Laboratory Department, University Hospital of Nancy, VANDOEUVRE, France
¹⁴Institut Curie, Alliance Mondiale Contre le Cancer, Paris, France
¹⁵Hematology Department, University Hospital of Nancy, Vandoeuvre, France